The impact of London's Ultra Low Emission Zone on respiratory prescribing: a synthetic control study
This synthetic control study finds that London's Ultra Low Emission Zone (ULEZ) had minimal and often negligible impacts on both PM2.5 air pollution levels and respiratory medication prescribing across its three implementation stages, suggesting that the policy's health benefits are considerably smaller than previously reported.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Cities are often choked by a haze of invisible particles, a byproduct of traffic that settles deep into the lungs and aggravates breathing problems. For decades, scientists have known that this air pollution contributes to heart disease, stroke, and respiratory failures, affecting millions of people every year. To fight back, many urban centers have introduced zones where the most polluting vehicles are charged a daily fee to enter, hoping that fewer dirty cars will mean cleaner air and healthier people. London, one of the world's most populous cities, has been a testing ground for this approach with its Ultra Low Emission Zone, which has expanded in three distinct waves over several years. While the policy has sparked intense political debate, the question of whether it actually improves the health of the people living inside the zone has remained difficult to answer with certainty.
A team of researchers from the University of Manchester set out to find that answer by looking at the real-world consequences of London's three-stage expansion. Instead of relying on roadside sensors that might miss the bigger picture, they used a sophisticated statistical method to compare the health of people living inside the zone against a carefully constructed group of similar people living outside it. They focused on two things: the actual amount of fine particulate matter in the air, and the number of prescriptions doctors wrote for breathing medications like inhalers. By tracking these numbers month by month, they could see if the policy caused a change in air quality and whether that change translated into fewer people needing medical help for their lungs.
The results were surprisingly modest. When the first stage of the zone opened in central London, the study found a tiny, almost imperceptible drop in pollution levels, just under one percent. This small change did not lead to any noticeable difference in how many people were prescribed breathing medication. The story became more complicated with the second expansion. In a twist that puzzled the researchers, the data showed a paradoxical rise in pollution levels of nearly three percent shortly after the zone grew larger. Despite this increase in pollution, the number of prescriptions for a specific type of steroid inhaler dropped, yet the strength of the medication people were using went up significantly. This suggests that while fewer new patients might have been seeking help, those who were already suffering from respiratory issues may have experienced a worsening of their condition, requiring stronger doses to manage their symptoms.
The final expansion, which covered all of Greater London, showed a return to a reduction in pollution, with levels dropping by about the same amount they had risen during the second stage. This time, there was a small but measurable decrease in the usage of bronchodilator medications, which are used to open up the airways. However, the researchers noted that even this improvement was far smaller than what other reports had claimed, and the benefits to public health remained limited. The study also looked at whether the cleaner air spread to the neighborhoods just outside the zone, finding that any positive effects stopped almost immediately at the boundary, with no significant spillover into surrounding areas.
Ultimately, the study concludes that while the Ultra Low Emission Zone did alter the air quality in London, the changes were much smaller than previously thought and did not lead to the dramatic improvements in respiratory health that many had hoped for. The researchers suggest that the policy alone may not be enough to solve the problem, and that it likely needs to be part of a much broader set of measures to truly protect public health. The findings serve as a reminder that while reducing vehicle emissions is a necessary step, the path from cleaner air to healthier lungs is complex and may require more than just a single policy change to navigate successfully.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.